ANTH Anthera Pharmaceuticals, Inc. gains 32% Feb 28, 2018

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of immunoglobulin A nephropathy. The company was founded in 2004 and is headquartered in Hayward, CA, US. http://www.priceseries.com/trade/ANTH-Anthera-Pharmaceuticals-Inc-stock-gains-32-percent-a-Trade-Record-by-priceSeries-2018021320180228.html